Cargando…
Esculetin releases maturation arrest and induces terminal differentiation in leukemic blast cells by altering the Wnt signaling axes
BACKGROUND: The “Differentiation therapy” has been emerging as a promising and more effective strategy against acute leukemia relapses. OBJECTIVE: In extension to the revolutionising therapeutic outcomes of All Trans Retinoic Acid (ATRA) to induce terminal differentiation of Acute Promyelocytic Leuk...
Autores principales: | Mathur, Ankit, Gangwar, Aman, Saluja, Daman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150528/ https://www.ncbi.nlm.nih.gov/pubmed/37127581 http://dx.doi.org/10.1186/s12885-023-10818-1 |
Ejemplares similares
-
Esculetin induces antiproliferative and apoptotic response in pancreatic cancer cells by directly binding to KEAP1
por: Arora, Rashi, et al.
Publicado: (2016) -
Esculetin Downregulates the Expression of AML1-ETO and C-Kit in Kasumi-1 Cell Line by Decreasing Half-Life of mRNA
por: Sawney, Sharad, et al.
Publicado: (2015) -
Lipid Mediators and Human Leukemic Blasts
por: Fiancette, Rémi, et al.
Publicado: (2011) -
Pharmacological and Therapeutic Applications of Esculetin
por: Garg, Sourbh Suren, et al.
Publicado: (2022) -
Esculetin Inhibits the Survival of Human Prostate Cancer Cells by Inducing Apoptosis and Arresting the Cell Cycle
por: Turkekul, Kader, et al.
Publicado: (2018)